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A B S T R A C T
Background
Measurement of cervical length by ultrasound is predictive of preterm birth (PTB). There are three methods of ultrasound cervical
assessment: transvaginal (TVU), transabdominal (TAU), and transperineal (TPU, also called translabial). Cervical length measured
by TVU is a relatively new screening test, and has been associated with better prediction of PTB than previously available tests. It is
unclear if cervical length measured by ultrasound is effective for preventing PTB. This is an update of a review last published in 2013.
Objectives
To assess the effectiveness of antenatal management based on transvaginal, transabdominal, and transperineal (also called translabial)
ultrasound screening of cervical length for preventing preterm birth.
Search methods
For this update, we searched the Cochrane Pregnancy and Childbirth’s Trials Register, ClinicalTrials.gov, and the WHO International
Clinical Trials Registry Platform (ICTRP) to 30 August 2018; reviewed the reference lists of all articles, and contacted experts in the
field for additional and ongoing trials.
Selection criteria
We included published and unpublished randomised controlled trials (RCT) including pregnant women between the gestational ages
of 14 to 32 weeks, for whom the cervical length was screened for risk of PTB with TVU, TAU, or TPU. This review focused on studies
based on knowledge versus no knowledge of cervical length results, or ultrasound versus no ultrasound for cervical length. We excluded
studies based on interventions (e.g. progesterone, cerclage) for short cervical length.
Data collection and analysis
We followed standard Cochrane methods.
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Main results
We included seven RCTs (N = 923): one examined asymptomatic women with twin pregnancies; four included women with singleton
pregnancies and symptoms of preterm labour (PTL); one included women with singleton pregnancies and symptoms of preterm
premature rupture of membranes (PPROM); and one included asymptomatic singletons. All trials used TVU for screening.
We assessed the risk of bias of the included studies as mixed, and the quality of the evidence for primary outcomes as very low for all
populations.
For asymptomatic women with twin pregnancies, it is uncertain whether knowledge of TVU-measured cervical length compared to
no knowledge reduces PTB at less than 34 weeks (risk ratio (RR) 0.62, 95% confidence intervals (CI) 0.30 to 1.25; 1 study, 125
participants) because the quality of the evidence is very low. The results were also inconclusive for preterm birth at 36, 32, or 30 weeks;
gestational age at birth, and other maternal and perinatal outcomes.
Four trials examined knowledge of TVU-measured cervical length of singletons with symptoms of PTL versus no knowledge. We are
uncertain of the effects because of inconclusive results and very low-quality evidence for: preterm births at less than 37 weeks (average
RR 0.59, 95% CI 0.26 to 1.32; 2 studies, 242 participants; I² = 66%; Tau² = 0.23). Birth occurred about four days later in the
knowledge groups (mean difference (MD) 0.64 weeks, 95% CI 0.03 to 1.25; 3 trials, 290 women). The results were inconclusive for
the other outcomes for which there were available data: PTB at less than 34 or 28 weeks; birthweight less than 2500 g; perinatal death;
maternal hospitalisation; tocolysis; and steroids for fetal lung maturity.
The trial of singletons with PPROM (N = 92) evaluated safety of using TVU to measure cervical length in this population as its primary
outcome, not its effect on management. The results were inconclusive for incidence of maternal and neonatal infections between the
TVU and no ultrasound groups.
In the trial of asymptomatic singletons (N = 296), in which women either received TVU or not, the results were inconclusive for
preterm birth at less than 37 weeks (RR 1.27, 95% CI 0.61 to 2.61; I² = 0%), gestational age at birth, and other perinatal and maternal
outcomes.
We downgraded evidence for limitations in study design, inconsistency between the trials, and imprecision, due to small sample size
and wide confidence intervals crossing the line of no effect.
No trial compared the effect of knowledge of the CL with no knowledge of CL in other populations, such as asymptomatic women
with singleton pregnancies, or symptomatic women with twin pregnancies.
Authors’ conclusions
There are limited data on the effects of knowing the cervical length, measured by ultrasound, for preventing preterm births, which
preclude us from drawing any conclusions for women with asymptomatic twin or singleton pregnancies, singleton pregnancies with
PPROM, or other populations and clinical scenarios.
Limited evidence suggests that knowledge of transvaginal ultrasound-measured cervical length, used to inform the management of
women with singleton pregnancies and symptoms of preterm labour, appears to prolong pregnancy by about four days over women in
the no knowledge groups.
Future studies could look at specific populations separately (e.g. singleton versus twins; symptoms versus no symptoms of PTL), report
on all pertinent maternal and perinatal outcomes, and include cost-effectiveness analyses. Most importantly, future studies should
include a clear protocol for management of women based on TVU-measured cervical length.
P L A I N L A N G U A G E S U M M A R Y
Cervical assessment by ultrasound for preventing preterm delivery
We set out to assess the effectiveness of knowing the cervical length, measured with ultrasound, for preventing preterm birth compared
with not knowing the cervical length.
What is the issue?
The cervix is the lower part of the uterus that connects to the vagina. When women are not pregnant, it is normally at least 3 cm long.
During pregnancy, a short cervical length is associated with a risk of spontaneous preterm birth. The shorter the cervical length, the
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greater the risk. Therefore, measuring cervical length by ultrasound can help predict spontaneous preterm birth. The cervical length is
measured by an ultrasound scan through the vagina (transvaginal or TVU), abdomen (transabdominal), or the perineum (transperineal).
The most common causes of spontaneous preterm birth are preterm labour or preterm premature rupture of the membranes. Many of
the interventions used to prevent preterm birth are used once symptoms develop.
Why is this important?
Preterm birth before 37 weeks is the main cause of a newborn baby being sick and disabled, or dying. The cervix is the opening or
passage through which the baby must pass before being born vaginally. Ultrasound can detect early changes of the cervix, such as
shortening of the cervical length, to predict preterm birth. On identifying a short cervical length, interventions can be applied to
prevent preterm birth. These interventions include giving the expectant mother progesterone to relax the uterus, or applying a stitch,
known as a cerclage, to tighten the opening of the cervix.
What evidence did we find?
This review assessed if knowing the cervical length can prevent preterm birth. We included seven randomised controlled studies, which
involved 923 pregnant women at 14 to 32 weeks’ gestation. One study included expectant mothers with twins, without any symptoms
of preterm birth or labour, and looked at the number of babies born prematurely before 36 weeks. Four studies included expectant
mothers of single babies with threatened preterm labour, and one study involving women with premature rupture of the membranes
looked at the safety of transvaginal ultrasound. One trial included expectant mothers with singleton pregnancies who did not have
any symptoms of preterm birth or labour to look at the efficacy of transvaginal ultrasound cervical length screening. All studies used
transvaginal ultrasound to assess cervical length.
For women with twin pregnancies and not showing symptoms of preterm birth, we are unclear of the impact of knowing the cervical
length on whether babies are born before 34 weeks’ gestation, or their gestational age at birth (1 study, 125 women), because we assessed
the quality of the evidence to be very low. For women with a single baby and threatened preterm labour, knowledge of their cervical
length may have led to a longer pregnancy by about four days (4 studies, 410 women), but the evidence on the number of babies born
before 37 weeks was unclear (2 studies, 242 women). For women whose waters had broken, it is unclear whether healthcare provider
knowledge makes any difference to whether the women gave birth preterm, or on the number of infections, again because we judged the
quality of evidence as very low. For women with singleton pregnancies not showing symptoms of preterm birth, it is unclear whether
an ultrasound to measure cervical length made any difference to whether their babies were born before 37 weeks’ gestation (1 study,
296 women; very low-quality evidence).
What does this mean?
We found a limited number of studies including small numbers of women. The studies varied in their design and had a broad spread
of results. Women were not blinded to whether they had an ultrasound or not. Currently, there is not enough high quality research to
show if knowledge of cervical length in women with twin or singleton pregnancies has any effect. Future studies could include ways
of managing women as a result of the cervical length results, and it would be useful to look at specific populations separately, such as
single babies versus twins and women with and without symptoms of preterm labour. They could also report on all important maternal
and perinatal outcomes, and include cost-effectiveness analyses.
3Cervical assessment by ultrasound for preventing preterm delivery (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length
Patient or population: women carrying twins, asymptomatic for PTL or PPROM
Setting: USA, sett ing not specif ied
Intervention: knowledge of TVU-measured cervical length (CL)
Comparison: no knowledge of CL
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with no knowledge
of CL
Risk with knowledge of
CL
Preterm birth < 34
weeks
Study populat ion (asymptomatic women carrying
twins)
RR 0.62
(0.30 to 1.25)
125
(1 RCT)
⊕©©©
VERY LOW a,b
258 per 1000 160 per 1000
(77 to 323)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; RR: risk rat io
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aWe downgraded 2 levels for very serious imprecision due to wide CI crossing the line of no ef fect, few events, and small
sample size
bWe downgraded 1 level for serious lim itat ions in study design, due to unclear risk of bias for several domains, and high risk
of performance bias
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B A C K G R O U N D
Description of the condition
Preterm birth (PTB) is defined by the World Health Organiza-
tion (WHO) as birth between 20 and 36 6/7 weeks. PTB can be
spontaneous, and follow preterm labour (PTL (50%)), or preterm
premature rupture of membranes (PPROM (30%)). It can also be
iatrogenic (caused by health worker intervention (20%). Its inci-
dence is about 5% to 12% in most countries, accounting for over
a million deaths per year in the world. PTB is the main cause of
neonatal morbidity and mortality in most countries. In the USA,
75% of perinatal mortality occurs in preterm babies; 60% of total
perinatal mortality occurs in infants born before 32 weeks. Mor-
tality and morbidities are inversely associated with gestational age
at birth. Morbidities include respiratory distress syndrome, bron-
chopulmonary dysplasia, intraventricular haemorrhage, necrotiz-
ing enterocolitis, sepsis, retinopathy, etc. The whole family suffers
greatly in several aspects when a baby has been born prematurely,
including medically, socially, psychologically, and financially.
Description of the intervention
Many of the interventions studied have been aimed at ter-
tiary prevention, i.e. prevention once symptoms (e.g. PTL or
PPROM) develop. Interventions based on risk factors, usually
based on prior history, have been more recently developed. There
are three methods of ultrasound cervical assessment: transvagi-
nal (TVU), transabdominal (TAU), and transperineal (TPU, also
called translabial). Cervical length measured by transvaginal ul-
trasound (TVU) is a relatively new screening test, and has been
associated with better prediction of PTB than previously available
tests (Berghella 2003, Berghella 2017,Navathe 2019). Interven-
tions based on this screening test have now been tested in ran-
domised trials.
How the intervention might work
Cervical assessment by ultrasound has been correlated with the
prediction of spontaneous PTB (Berghella 2003). Themost objec-
tive and effective ultrasoundmethod isTVU(Hernandez-Andrade
2012; Khalifeh 2016). The most predictive and reproducible vari-
able that can be measured on TVU is cervical length. The gesta-
tional age at which TVU cervical length is most predictive of PTB
is 14 to 34 weeks, but shortening at earlier and later gestational
ages is also associated with PTB. The shorter the cervical length,
the higher the risk of PTB becomes (Grimes-Dennis 2007). The
earlier in gestation the shortening is detected, the higher the risk
of PTB (Berghella 2007). This prediction has been confirmed in
all populations screened with TVU cervical length so far, includ-
ing singleton and multiple pregnancies, women with or without
risk factors for PTB (e.g. prior PTB, mullerian anomalies, cervical
surgery, etc.), asymptomatic women, as well as those with PTL or
PPROM (Grimes-Dennis 2007). In fact, TVU cervical length is
one of the best predictors of PTB in all populations studied so far.
The overall sensitivity and specificity vary according to the cervical
length cut-off used (e.g. 25 mm versus 20mm versus 15mm); ges-
tational age at screening; population studied; prevalence of PTB;
single versus serial screening; etc. Its positive predictive value also
varies depending on the incidence of PTL in the population stud-
ied. The intervention of cervical length assessment by ultrasound
has been studied in combination with other interventions (e.g.
cerclage, progesterone, pessary, etc.) for prevention of PTB, and
the reader is encouraged to read these specific Cochrane Reviews
(e.g. progesterone (Dodd 2017a; Dodd 2017b), cerclage (Alfirevic
2017; Rafael 2014); or pessary (Abdel-Aleem 2013). Knowledge
of cervical length assessment by ultrasound per se can also be con-
sidered an intervention, and is the topic of this review. In addition,
cervical length assessment could also reduce the need for other
interventions (e.g. activity restriction, tocolytics, steroids, etc.).
Why it is important to do this review
PTB is the main cause of neonatal morbidity and mortality in
most countries. It account for a neonatal death every 30 seconds
globally, and millions of babies are affected by its consequences
every year. Mortality and morbidities are inversely associated with
gestational age at birth. Morbidities include respiratory distress
syndrome, bronchopulmonary dysplasia, intraventricular haemor-
rhage, necrotizing enterocolitis, sepsis, retinopathy, etc. Thewhole
family suffers greatly in several aspects when a baby has been born
prematurely, including medically, socially, psychologically, and fi-
nancially. This is an update of a review last published in 2013
(Berghella 2013).
O B J E C T I V E S
To assess the effectiveness of antenatal management based
on transvaginal, transabdominal, and transperineal (also called
translabial) ultrasound screening of cervical length for preventing
preterm birth.
M E T H O D S
Criteria for considering studies for this review
Types of studies
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Published and unpublished randomised controlled trials. We had
planned to include cluster-randomised and quasi-randomised tri-
als, if available. Abstracts were eligible for inclusion if sufficient
information was provided to judge the quality and potential for
bias of these trials.
Types of participants
Pregnant women between the gestational ages of 14 to 34 weeks,
screened with transvaginal (TVU), transabdominal (TAU), or
transperineal (TPU) cervical length for risk of preterm birth
(PTB). Given the different characteristics of singleton versus
twin pregnancies; women with asymptomatic versus symptomatic
preterm labour (PTL) or preterm premature rupture of mem-
branes (PPROM); and PTL versus PPROM; we divided compar-
isons into:
• asymptomatic singletons
• asymptomatic with twins
• singletons with PTL
• singleton with PPROM
• twins with PTL
• twins with PPROM
We had planned to divide the analysis by the type of cervical
length ultrasound screening, i.e. TVU versus TAU versus TPU.
We carried out analysis of other participants by type of population,
as described under ’subgroup analyses’.
Trials that did not measure the outcome of interest, as well as trials
using manual digital cervical examination as control group were
excluded.
Types of interventions
A screening test such as clinical length can only be considered ef-
fective if the interventions based on screening results reduce the
outcome of preterm birth. For this review, we included the follow-
ing screening cervical length modalities on which interventions
were based.
• Knowledge versus no knowledge of cervical length results
(i.e. cervical length is assessed for all women, but women are
randomised so that in about 50% of them, the result is available
to the managing obstetrician, while in about 50%, the managing
obstetrician is blind to the result).
• Cervical length screening versus no cervical length
screening (TVU/TAU/TPU cervical length screening is only
performed on half of the women).
Types of outcome measures
Primary outcomes
1. Preterm birth (less than 37 weeks for singleton pregnancies;
less than 34 weeks for twin pregnancies)
Secondary outcomes
1. Preterm birth (less than 36 weeks)
2. Preterm birth (less than 34 weeks)
3. Preterm birth (less than 32 weeks)
4. Preterm birth (less than 30 weeks)
5. Preterm birth (less than 28 weeks)
6. Gestational age at delivery
7. Birthweight less than 2500 g
8. Birthweight (g)
9. Composite perinatal outcome (perinatal death, respiratory
distress syndrome, intraventricular haemorrhage, necrotizing
enterocolitis, and sepsis)
10. Perinatal death (fetal death and neonatal death)
11. Fetal death
12. Neonatal death
13. Neonatal infection
14. Respiratory distress syndrome
15. Intraventricular haemorrhage
16. Necrotizing enterocolitis
17. Sepsis
18. Neonatal intensive care unit (NICU) admission
19. NICU days
20. Maternal hospitalisation
21. Maternal well-being (e.g. stress level, etc.)
22. Economic analysis (cost effectiveness, cost utility)
23. Tocolysis
24. Cervical cerclage
25. Steroids for fetal maturity
26. Chorioamnionitis
27. Endometritis
Search methods for identification of studies
The followingmethods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Electronic searches
For this update, we searchedCochrane Pregnancy and Childbirth’s
Trials Register by contacting their Information Specialist (30 Au-
gust 2018).
The Register is a database containing over 24,000 reports of con-
trolled trials in the field of pregnancy and childbirth. It represents
over 30 years of searching. For full current search methods used
to populate Pregnancy and Childbirth’s Trials Register, including
the detailed search strategies for CENTRAL, MEDLINE, Em-
base, and CINAHL; the list of handsearched journals and confer-
ence proceedings; and the list of journals reviewed via the current
awareness service, please follow this link.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist, and contains trials
identified from:
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1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE Ovid;
3. weekly searches of Embase Ovid;
4. monthly searches of CINAHL EBSCO;
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals,
plus monthly BioMed Central email alerts.
Search results are screened by two people, and the full text of all
relevant trial reports identified through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
cific Pregnancy and Childbirth review topic (or topics), and is
then added to the Register. The Information Specialist searches the
Register for each review using this topic number rather than key-
words. This results in a more specific search set that has been fully
accounted for in the relevant review sections (Included studies;
Excluded studies; Ongoing studies).
In addition, we searched ClinicalTrials.gov and the WHO Inter-
national Clinical Trials Registry Platform ( ICTRP) for unpub-
lished, planned, and ongoing trial reports (30 August 2018), using
the search methods detailed in Appendix 1.
Searching other resources
We reviewed the reference list of all retrieved articles. If necessary,
we contacted researchers to provide further information. We con-
tacted experts in the field for additional and ongoing trials.
We did not apply any language or date restrictions.
Data collection and analysis
For methods used in the previous version of this review, see
Berghella 2013.
For this update, the following methods were used to assess the
reports that were identified as a result of the updated search.
Selection of studies
Two review authors independently assessed for inclusion all the
potential studies identified as a result of the search strategy. We re-
solved any disagreement through discussion. Two ongoing studies
are being conducted by one of the authors of this review, so these
were assessed by the Cochrane Pregancy and Childbirth Group
staff (NCT02923973; NCT02928302).
Data extraction and management
Wedesigned a form to extract data. Data were entered into Review
Manager 5 software, and checked for accuracy (Review Manager
2014). One of the authors of this Cochrane Review (Vincenzo
Berghella) is a co-author of one of the included trials (Ness 2007),
and the other author (Gabriele Saccone) is lead author on two
ongoing trials (NCT02923973; NCT02928302). Gabriele Sac-
cone assessed the eligibility and risk of bias for Ness 2007; the
Cochrane Pregancy and Childbirth editorial staff assessed the el-
igibility of NCT02923973 and NCT02928302. The two review
authors independently assessed the other potential studies, iden-
tified as a result of the search strategy for inclusion. We resolved
any disagreement through discussion.
When information regarding any of the above was unclear, we
had planned to contact authors of the original reports to provide
further details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011). Any disagreement
was resolved by discussion.
(1) Random sequence generation (checking for possible
selection bias)
For each included study, we described themethod used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
For each included study, we described the method used to con-
ceal allocation to interventions prior to assignment, and assessed
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered, sealed, opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
For each included study, we described the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if theywere blinded, or if we judged that the
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lack of blinding was unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high, or unclear risk of bias for participants;
• low, high, or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
For each included study, we described the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high, or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
For each included study, and for each outcome or class of out-
comes, we described the completeness of data including attrition
and exclusions from the analysis. We stated whether attrition and
exclusions were reported, and the numbers included in the analysis
at each stage (compared with the total randomised participants),
reasons for attrition or exclusion where reported, and whether
missing data were balanced across groups or were related to out-
comes. Where sufficient information was reported, or could be
supplied by the trial authors, we planned to re-include missing
data in the analyses which we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
For each included study, we described how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it was clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review have been reported);
• high risk of bias (where not all the study’s pre-specified
outcomes have been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest were
reported incompletely and so could not be used; study failed to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
For each included study, we described any important concerns we
had about other possible sources of bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Cochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011). With
reference to (1) to (6) above, we had planned to assess the likely
magnitude and direction of the bias and whether we considered
it was likely to impact on the findings. In future updates, we will
explore the impact of the level of bias through undertaking sensi-
tivity analyses - see Sensitivity analysis.
Assessment of the quality of the evidence using the
GRADE approach
For this update, we used the GRADE approach, as outlined in the
GRADE Handbook, in order to assess the quality of the body of
evidence relating to the primary outcome (preterm birth less than
37 weeks for singleton pregnancies; less than 34 weeks for twin
pregnancies) for the following comparisons (GRADEHandbook).
1. Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (asymptomatic women with
twins)
2. Knowledge versus no knowledge of transvaginal ultrasound
(TVU)-measured cervical length (symptomatic singletons with
preterm labour (PTL))
WeusedGRADEproGDTto import data fromReviewManager 5
to create ’Summary of findings’ tables (GRADEproGDT; Review
Manager 2014). The GRADE approach uses five considerations
(study limitations, consistency of effect, imprecision, indirectness,
and publication bias) to assess the quality of the body of evidence
for each outcome. The evidence can be downgraded from high
quality by one level for serious (or by two levels for very serious)
limitations, depending on assessments for risk of bias, indirectness
of evidence, serious inconsistency, imprecision of effect estimates,
or potential publication bias.
Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
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Continuous data
We used the mean difference if outcomes were measured in the
same way between trials. In future updates, as appropriate, we
plan to use the standardised mean difference to combine trials that
measure the same outcome, but use different methods.
Unit of analysis issues
Cluster-randomised trials
We had planned to include cluster-randomised trials in the anal-
yses along with individually-randomised trials, however, all in-
cluded studies were individually-randomised trials.
Dealing with missing data
For included studies, we noted levels of attrition. We had planned
to explore the impact of including studies with high levels of miss-
ing data in the overall assessment of treatment effect by using sen-
sitivity analysis, however, because most trials had a unique com-
parison, there were too few data available to carry out ameaningful
sensitivity analysis.
For all outcomes, we carried out analyses, as far as possible, on
an intention-to-treat basis, i.e. we attempted to include all partic-
ipants randomised to each group in the analyses, and all partici-
pants were analysed in the group to which they were allocated, re-
gardless of whether or not they received the allocated intervention.
The denominator for each outcome in each trial was the number
randomised minus any participants whose outcomes were known
to be missing.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the Tau², I², and Chi² statistics. We regarded heterogeneity as
substantial if an I² was greater than 30%, and either the Tau² was
greater than zero, or there was a low P value (less than 0.10) in the
Chi² test for heterogeneity.
Assessment of reporting biases
In future updates, if there are 10 or more studies in the meta-
analysis, we will investigate reporting biases (such as publication
bias) using funnel plots. We will assess funnel plot asymmetry
visually. If asymmetry is suggested by a visual assessment, we will
perform exploratory analyses to investigate it.
Data synthesis
We carried out statistical analysis usingReviewManager 5 software
(Review Manager 2014). We used a fixed-effect meta-analysis for
combiningdatawhere itwas reasonable to assume that studieswere
estimating the same underlying treatment effect, i.e. where trials
were examining the same intervention, and the trials’ populations
and methods were judged sufficiently similar.
If there was clinical heterogeneity sufficient to expect that the un-
derlying treatment effects differed between trials, or if substan-
tial statistical heterogeneity was detected, we used a random-ef-
fects meta-analysis to produce an overall summary, if an average
treatment effect across trials was considered clinically meaningful.
We treated the random-effects summary as the average range of
possible treatment effects, with 95% confidence intervals, and the
estimates of Tau² and I², and discussed the clinical implications of
treatment effects differing between trials. If the average treatment
effect was not clinically meaningful, we did not combine trials.
Subgroup analysis and investigation of heterogeneity
We planned the following subgroup analyses, classifying whole
trials by interaction tests as described by Deeks 2001.
1. Women with singleton pregnancies without prior
spontaneous PTB
2. Women with singleton pregnancies with prior spontaneous
PTB
We had planned to restrict subgroup analyses to the primary out-
come.
We had planned to assess subgroup differences by interaction tests
available within Review Manager 5 (Review Manager 2014).
None of the included studies reported results separately for sin-
gleton pregnancies based on prior or no prior spontaneous PTB,
so we could not perform the planned subgroup analysis. In future
updates, assuming we have sufficient data, we will report the re-
sults of subgroup analyses, quoting the Chi² statistic and P value,
and the interaction test I² value.
Sensitivity analysis
We had planned to carry out sensitivity analyses to explore the
effect of the trials’ methodological quality, assessed by concealment
of allocation, high attrition rates, or both, when studies with high
risk of bias were excluded from the analyses, to assess whether this
made any difference to the overall result.
We did not carry out a sensitivity analysis because most meta-
analyses only included data from one or two studies.
R E S U L T S
Description of studies
Results of the search
See: Figure 1.
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Figure 1. Study flow diagram
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For this 2018 update, we identified 17 trial reports to assess. We
included two new trials in three reports (Mishra 2018; Vafaei
2017); and five reports related to three already included studies
(Gordon 2016; Ness 2007; Palacio 2018). We excluded four new
trials in five reports (Gauthier 2014;Hosseini 2012;Romero2014;
Schnettler 2013); and added three ongoing studies in four reports
(NCT01431885; NCT02923973; NCT02928302).
In this update, we included a total of seven trials (N = 923). We
identified no quasi-randomised trials. All seven included studies
used transvaginal (TVU) cervical length screening, versus either
no TVU cervical length screening, or no knowledge of the results
of TVU cervical length screening. We did not identify any studies
that used transabdominal or transperineal ultrasound for cervical
length screening.
Included studies
The seven included studies included: one trial on women with
twins, who were asymptomatic for preterm labour (PTL (Gordon
2016)); four trials on women with singleton pregnancies, who
had symptoms of PTL (Alfirevic 2007; Ness 2007; Palacio 2018;
Vafaei 2017); one trial on women with singleton pregnancies, who
had preterm premature rupture of membranes (PPROM (Carlan
1997)); no trials included women with twin pregnancies, who
were symptomatic for either PTL or had PPROM.
Five studies did not measure cervical length with TVU in the con-
trol groups (Alfirevic 2007; Carlan 1997; Gordon 2016; Mishra
2018; Vafaei 2017); and two studies used TVU to measure cervi-
cal length on all women, but only disclosed knowledge of cervical
length to women and physicians in the intervention group (Ness
2007; Palacio 2018).
We requested patient-level data frommost of the trial authors, and
obtained them from one (Ness 2007).
In the one trial of women with twin pregnancies, who were asymp-
tomatic for PTL, the analysis included 63 women who had TVU-
measured cervical length and 62 who did not (Gordon 2016).
In the three trials of women with singleton pregnancies, who had
symptoms of PTL, 410 women were randomised; 212 to knowl-
edge, and 198 to no knowledge of TVU-measured cervical length
(Alfirevic 2007; Ness 2007; Palacio 2018). Ness 2007 used knowl-
edge of the cervical length in themanagement protocol; forwomen
with cervical length 20 mm to 29 mm, they also used fetal fi-
bronectin levels (FFN).
In the one trial ofwomenwith singletonpregnancies andPPROM,
the analysis included 47 women who had TVU measurement of
cervical length, and 45 who did not (Carlan 1997).
Funding
Only one trial reported on funding, and reported that the study
was funded by The Fetal Medicine Foundation (Registered Char-
ity 1037116 (Alfirevic 2007)), and one trial reported support from
theVice-Chancellor of Research, Shiraz University ofMedical Sci-
ences, Shiraz, Iran (Vafaei 2017). None of the other trials reported
on funding.
Declarations of interest
Two studies reported that the authors had no conflicts of interest
(Mishra 2018; Vafaei 2017). In the remaining studies, they did
not report on declarations of interest.
Dates of study
Dates were not reported in two studies (Gordon 2016; Vafaei
2017). The dates were reported as follows in the remaining studies:
2003 to 2005 (Alfirevic 2007); May 1993 to June 1996 (Carlan
1997); July 2014 to December 2015 (Mishra 2018); November
2004 to April 2006 (Ness 2007); and January 2002 to April 2005
(Palacio 2018).
Excluded studies
We excluded a total of 12 trials (14 reports); three because
they compared history-indicated to ultrasound-indicated cerclage
(Beigi 2005; Kassanos 2001; Simcox 2009); one because the TVU-
measured cervical length information was blinded and not used
for management (Matijevic 2006); one because TVU informa-
tion was not used for clinical care and no data on outcomes were
provided (Owen 1999); two trials were excluded because control
group was not ’no ultrasound’ or ’no knowledge’, but was manual
digital cervical examination, interestingly, these studies utilized
transabdominal ultrasound (Lorenz 1990; Van Dijken 1991); one
because it used Cervilenz, which measures the vaginal part of the
cervix rather than cervical length (Burwick 2011); one because
TVU was compared to TPU, therefore with no ’no knowledge’
group (Gauthier 2014); one because it was unclear if women were
randomised to knowledge versus no knowledge of cervical length
groups, and no outcome of interest was reported (Hosseini 2012);
and one because no data on any outcomes of interest were mea-
sured and available, as this was a trial assessing only visit length
and patient attitudes (Romero 2014).
Risk of bias in included studies
See Figure 2 and Figure 3 for summaries of ’Risk of bias’ assess-
ments.
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Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study
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Allocation
We assessed risk of selection bias as low in four trials (Alfirevic
2007; Carlan 1997; Ness 2007; Palacio 2018). Alfirevic 2007,
Ness 2007, and Palacio 2018 used computer-generated random
numbers for sequence generation, and Carlan 1997 reported that
they used randomly-generated assignment in sealed envelopes.
Alfirevic 2007, Carlan 1997, and Gordon 2016 reported using
consecutively numbered, sealed envelopes and Palacio 2018 used
a central telephone operated platform.
Although Mishra 2018 used computer-generated randomisation,
they reported no details related to allocation concealment, so we
assessed it as unclear. The other two studies reported no infor-
mation on methods of randomisation or allocation concealment,
so we assessed them as unclear for selection bias (Gordon 2016;
Vafaei 2017).
Blinding
We assessed risk of performance bias as high in all trials, as partic-
ipants and researchers were aware of the arm to which they were
randomised, but this was inevitable.
In two trials, the primary outcomes were objective measures, so
we assessed detection bias at low risk (Alfirevic 2007; Gordon
2016). It was unclear in other trials if outcome assessment had
been blinded.
Incomplete outcome data
Information regarding an intention-to-treat analysis was available
for three of the seven trials. Two trials included all women ran-
domised in the intention-to-treat analysis (Alfirevic 2007; Ness
2007). In Carlan 1997, one of the 93 (1%) women randomised
was excluded from the analysis because she delivered immediately.
In one study, there were no losses to follow-up (Vafaei 2017). We
assessed these four studies at low risk of attrition bias. We assessed
two trials as high risk because women lost to follow-up were ex-
cluded from the analysis (Mishra 2018; Palacio 2018). We could
not assess incomplete outcome data in one trial because the trial
was only reported as an abstract, so data were limited (Gordon
2016).
Selective reporting
We assessed risk of selective reporting as unclear in four trials due
to a lack of information (Gordon 2016; Mishra 2018; Palacio
2018; Vafaei 2017); and at low risk of bias in the remaining trials
as they reported all expected specified outcomes.
Other potential sources of bias
We assessed the risk of other potential sources of bias as unclear
in two trials; one did not include a baseline characteristics table
(Carlan 1997), and another did not provide sufficient information
to allow us to assess (Gordon 2016). We judged the remaining
studies at low risk of bias from other sources.
Effects of interventions
See: Summary of findings for the main comparison
Asymptomatic women with twins (no preterm labour (PTL) or
preterm premature rupture of membranes (PPROM)); Summary
of findings 2 Symptomatic singletons (with preterm labour
(PTL))
We included seven trials in this review (N = 923).
We found the risk of bias of the included studies to be mixed.
For selected important comparisons for the primary outcome, we
graded the quality of the evidence as very low, see Summary of
findings for the main comparison and Summary of findings 2.
Knowledge of transvaginal ultrasound (TVU)-
measured cervical length versus no knowledge
(asymptomatic women with twins)
The effect of knowing the TVU-measured cervical length is un-
clear due to very low-quality evidence from a single trial (Summary
of findings for the main comparison; Gordon 2016).
In women with twin pregnancies, and without symptoms of
preterm labour (PTL), it is uncertain whether TVU-measured cer-
vical length reduces preterm birth at less than 36 weeks’ gestation
(risk ratio (RR) 1.27, 95% confidence interval (CI) 0.85 to 1.90;
125 participants; Analysis 1.1); at less than 34 weeks (RR 0.62,
95% CI 0.30 to 1.25; 125 participants; Analysis 1.2; Summary
of findings for the main comparison); at less than 32 weeks (RR
0.56, 95% CI 0.17 to 1.83; 125 participants; Analysis 1.3); or at
less than 30 weeks’ gestation (RR 0.20, 95% CI 0.02 to 1.64; 125
participants; Analysis 1.4), because the quality of the evidence is
very low.
The results were also inconclusive for gestational age at deliv-
ery (weeks) (mean difference (MD) 0.20, 95% CI -0.74 to 1.14;
125 participants; Analysis 1.5),maternal hospitalisation (RR1.29,
95% CI 0.75 to 2.23; 125 participants; Analysis 1.6), tocolysis
(RR 1.34, 95% CI 0.74 to 2.42; 125 participants; Analysis 1.7),
steroids for fetal lung maturity (RR 0.79, 95% CI 0.49 to 1.26;
125 participants; Analysis 1.8), or cervical cerclage (RR 4.92, 95%
CI 0.24 to 100.49; 125 participants; Analysis 1.9); or perinatal
outcomes: birthweight (MD 142.00, 95% CI -9.95 to 293.95;
250 participants; Analysis 1.10),NICU admission (RR 1.14, 95%
CI 0.83 to 1.55; 250 participants; Analysis 1.11),
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No other outcomes were reported in this trial.
Knowledge of transvaginal ultrasound (TVU)-
measured cervical length versus no knowledge
(singletons with symptoms of preterm labour (PTL))
Inwomenwith a singletonpregnancywhohave symptomsof PTL,
we are uncertain of the effects of knowledge of TVU-measured
cervical length on preterm births (PTB) at less than 37 weeks’
gestation (average RR 0.59, 95% CI 0.26 to 1.32; 2 studies, 242
participants; I² = 66%; Tau² = 0.23; very low-quality evidence;
Analysis 2.1; Summary of findings 2); and at less than 34 weeks
(RR 0.55, 95% CI 0.25 to 1.20; 3 studies, 256 participants;
Analysis 2.2. There were no preterm births at less than 28 weeks’
gestation.
Birth occurred at a slightly later gestational age in the cervical
length knowledge groups compared to the no knowledge groups
(weeks) (MD 0.64, 95% CI 0.03 to 1.25; 3 studies, 290 partici-
pants; Analysis 2.4).
These resultswere determinedmostly by theNess2007 trial, which
used TVU-measured cervical length as the main screening test
for guiding management, adding FFN levels to help determine
management in women with a cervical length of 20 mm to 29
mm. There were inconclusive results and often substantial hetero-
geneity for all other outcomes for which there were available data:
birthweight less than 2500 g (RR 0.71, 95% CI 0.21 to 2.44; 1
study, 70 participants; Analysis 2.5); maternal hospitalisation (RR
2.94, 95% CI 0.85 to 10.16; 1 study, 93 participants; Analysis
2.7), tocolysis (average RR 0.85, 95% CI 0.11 to 6.58; 2 studies,
102 participants; I² = 86%;Tau² = 1.89; Analysis 2.8); and steroids
for fetal lung maturity (average RR 1.72, 95% CI 0.15 to 19.64;
2 studies, 114 participants; I² = 91%; Tau² = 2.83; Analysis 2.9);
there were no perinatal deaths reported in either group. Appro-
priateness of treatment with steroids for fetal lung maturity was
higher in the knowledge versus the no knowledge group in the one
trial that evaluated this outcome (Alfirevic 2007).
Other maternal and fetal outcomes were not reported, or insuffi-
cient data were available for meaningful analysis.
Knowledge of transvaginal ultrasound (TVU)-
measured cervical length versus no knowledge
(singletons with preterm premature rupture of
membranes (PPROM))
One trial of women with a singleton pregnancy and PPROM eval-
uated the safety of using TVU to measure cervical length in this
population, and not the effect on management of knowing the
cervical length (Carlan 1997). They did not report the incidence
of preterm births or gestational age at delivery. The results were
inconclusive for birthweight (MD 31.00 g, 95% CI -162.16 to
224.16; 92 participants; Analysis 3.1), incidence of maternal in-
fections (chorioamnionitis: RR 0.72, 95% CI 0.34 to 1.52; 92
participants; Analysis 3.2, or endometritis: RR 1.39, 95% CI 0.33
to 5.88; 92 participants; Analysis 3.3), and neonatal infections
(RR 1.18, 95% CI 0.50 to 2.78; 92 participants; Analysis 3.4).
The trials did not report other outcomes.
Knowledge of transvaginal ultrasound (TVU)-
measured cervical length versus no knowledge
(asymptomatic singletons)
One trial examined the effects of the knowledge of TVU-mea-
sured cervical length for women with a singleton pregnancy, no
symptoms of PTL, and no history of spontaneous preterm birth
or second trimester loss (Mishra 2018). The results were incon-
clusive for maternal outcomes: preterm birth less than 37 weeks
(RR 1.27, 95% CI 0.61 to 2.61; 296 participants; Analysis 4.1);
and for neonatal outcomes: birthweight (MD -10.00 g, 95% CI -
135.17 to 115.17; 296 participants; Analysis 4.2); respiratory dis-
tress syndrome (RR 2.03, 95%CI 0.38 to 10.90; 296 participants;
Analysis 4.3); NICU admission (RR 2.03, 95% CI 0.19 to 22.12;
296 participants; Analysis 4.4); intraventricular haemorrhage (RR
0.51, 95% CI 0.05 to 5.53; 296 participants; Analysis 4.5); and
neonatal death (RR 0.20, 95% CI 0.01 to 4.19; 296 participants;
Analysis 4.6).
The trial did not report other outcomes.
Other comparisons
We did not identify any trials that assessed knowledge versus no
knowledge of TVU-measured cervical length inwomenwith twins
who had symptoms of PTL or PPROM.
We did not identify any trials that compared different types of
ultrasound.
Subgroup analysis and sensitivity analysis
None of the seven included trials reported data separately for sin-
gleton pregnancies with and without prior spontaneous preterm
births, so we could not perform that planned subgroup analysis.
We did not carry a sensitivity analysis because most meta-analyses
included data from only one or two studies.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length
Patient or population: singleton pregnancy with symptoms of PTL
Setting: hospital sett ings in Spain and USA
Intervention: knowledge of TVU-measured cervical length (CL)
Comparison: no knowledge of CL
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with no knowledge
of CL
Risk with knowledge of
CL
Preterm birth < 37
weeks
Study populat ion (symptomatic singletons) Average RR 0.59
(0.26 to 1.32)
242
(2 RCTs)
⊕©©©
VERY LOWa,b,c
347 per 1000 222 per 1000
(146 to 337)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; RR: risk rat io
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aWe downgraded 1 level for serious inconsistency due to high stat ist ical heterogeneity (66%)
bWe downgraded 2 levels for very serious imprecision due to a small sample size and wide conf idence intervals crossing the
line of no ef fect
cWe downgraded 1 level for serious lim itat ions in study design due to high risk of bias for several domains
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D I S C U S S I O N
Summary of main results
There are limited data on the effects of knowing the cervical length,
measured by ultrasound for preventing preterm births.
We were unable to determine the effects of the knowledge of
transvaginal ultrasound (TVU)-measured cervical length in the
management of asymptomatic women with either singleton or
twin pregnancies, because we found only one small trial that ex-
amined each population.
Knowledge of TVU-measured cervical length to inform the man-
agement of women with singleton pregnancies and symptoms of
preterm labour (PTL) appeared to result in births that occurred
about four days later than those born to women in the no knowl-
edge groups. Evidence on other outcomes such as the incidence
of preterm birth before 37 weeks, was unclear. We were unable
to determine the effect of knowledge of TVU-measured cervical
length in the management of women with singleton pregnancies
and preterm premature rupture of membranes (PPROM) because
we found just one small trial on this population. We identified no
trials of women with twin pregnancies with symptoms of either
PTL or PPROM.
There is limited and inconclusive evidence on how the knowledge
of cervical length, assessed by ultrasound could avoid unnecessary
interventions (e.g. tocolytics, steroids, etc.) in women with a nor-
mal cervical length.
Overall completeness and applicability of
evidence
All included trials used TVU to measure cervical length; no in-
cluded trials used transabdominal (TAU) or transperitoneal (TPU)
ultrasound. There were no trials comparing knowledge versus
no knowledge of TVU-measured cervical length in symptomatic
women with twin pregnancies.
Ness 2007 suggested a protocol of no intervention for womenwith
a TVU-measured cervical length of at least 30 mm; the addition of
FFN levels for the management of women with a cervical length
of 20 mm to 29 mm; and the administration of steroids for fetal
lung maturity and tocolysis for women with a cervical length less
than 20 mm (Ness 2007).
By design, our review did not include an assessment of the effec-
tiveness of interventions based on positive TVU-measured cervical
length (short cervical length), or negative TVU-measured cervical
length screening (normal or long cervical length). These are exam-
ined in Cochrane Reviews of the specific intervention (e.g. pro-
gesterone (Dodd 2017a; Dodd 2017b), cerclage (Alfirevic 2017;
Rafael 2014); and pessary (Abdel-Aleem 2013).
All the included trials tookplace in high-income settings and coun-
tries, therefore, our findings are limited to this type of setting.
Quality of the evidence
The seven included randomised studies were all relatively small,
and blinding was not possible; see Figure 2 and Figure 3.
For the comparison, knowledge of TVU-measured cervical length
versus no knowledge (asymptomatic women with twins), we as-
sessed the evidence to be very low quality for preterm birth less
than 34 weeks. We downgraded the quality for limitations in
study design, small sample size, and wide confidence intervals that
crossed the line of no effect; see Summary of findings for the main
comparison.
For the comparison, knowledge of TVU-measured cervical length
versus no knowledge (singletons with symptoms of PTL), we as-
sessed the evidence to be very low quality for preterm birth less
than 37 weeks.We downgraded the quality for limitations in study
design, high statistical heterogeneity, small sample size, and wide
confidence intervals that crossed the line of no effect; see Summary
of findings 2.
Potential biases in the review process
One of the authors of this Cochrane Review (Vincenzo Berghella)
is a co-author of one of the included trials (Ness 2007), and
the other author (Gabriele Saccone) is lead author on two ongo-
ing trials (NCT02923973; NCT02928302). Gabriele Saccone as-
sessed the eligibility and risk of bias for Ness 2007; the Cochrane
Pregancy and Childbirth editorial staff assessed the eligibility of
NCT02923973 and NCT02928302. The two review authors in-
dependently assessed the other potential studies, identified as a re-
sult of the search strategy for inclusion. We resolved any disagree-
ment through discussion.
Agreements and disagreements with other
studies or reviews
The evidence presented in this current update has added two new
trials (Mishra 2018; Vafaei 2017). Our overall conclusions remain
the same as those in the previous version (Berghella 2013). The re-
sults of this Cochrane review concur with another IPDmeta-anal-
ysis of three trials including a total of 287 singleton gestations with
threatened preterm labour between 24 + 0 and 35 + 6 weeks, that
showed that there is a significant association between knowledge
of transvaginal ultrasound cervical length and later gestational age
at delivery (Berghella 2017). However, our review found no good
quality evidence that there was an association between knowledge
of transvaginal ultrasound cervical length and a lower incidence
of preterm birth in women with singleton pregnancies and threat-
ened PTB, whereas Berghella 2017 did report an association. A
retrospective cohort study of women with asymptomatic singleton
gestations also suggested an association between TVU screening
and a reduction in preterm labour (Navathe 2019). Our review
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did not find the same finding in the single study identified of
asymptomatic women with a singleton gestation (Mishra 2018).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There are limited data on the effects of knowing the cervical length,
measured by ultrasound, for preventing preterm births, which pre-
clude us from drawing any conclusions.
Limited evidence suggests that knowledge of transvaginal ultra-
sound-measured cervical length, used to inform the management
of women with singleton pregnancies and symptoms of preterm
labour, appears to prolong pregnancy by about four days over
women in the no knowledge groups.
Implications for research
This review found limited evidence that suggested knowledge of
TVU-measured cervical length might increase slightly the age at
birth, but it had an unclear effect on preterm births at less than
37 weeks, and there were no clear differences in other outcomes,
possibly due to the small number of women with symptoms of
PTL. The review authors encourage further research. Future stud-
ies could look at specific populations separately (e.g. singleton ver-
sus twins; symptoms of PTL or no symptoms), report on all perti-
nent maternal and perinatal outcomes, and include cost-effective-
ness analyses. Most importantly, future studies should include a
clear protocol for the management of women’s pregnancies, based
on TVU-measured cervical length results, so that it can be easily
evaluated and replicated.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Alfirevic 2007
Methods RCT
Participants Singleton pregnancies; uterine contractions at < 34 weeks; and clinical decision to use
steroids and tocolytics. N = 41
Interventions TVU CL knowledge or not (the control group did not receive TVU CL)
Time TVU CL results available: not specified
Protocol for TVU knowledge group: yes
Outcomes Primary: incidence of women still pregnant at 7 days
Notes Intention-to-treat; only singletons; protocol for management of TVU CL group
Short TVU CL (< 15 mm): 7/21 (33%) in knowledge group; not done in other group
Funding: the study was funded by The Fetal Medicine Foundation (Registered Charity
1037116)
Dates of trial: from 2003 to 2005
Setting: 5 hospitals in the United Kingdom, 1 in Spain
Conflicts of interest: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
Allocation concealment (selection bias) Low risk Consecutively numbered sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and physicians knew which group was randomised to
’knowledge’ or ’no knowledge’
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Some blinding attempted - “Women allocated to the experi-
mental group had a transvaginal scan to measure the CL, which
was performed by a member of the research team who was not
involved in the care of the patient” - but the control group did
not have a transvaginal scan
Primary outcome - is an objective outcome (delivery within 7
days)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No incomplete outcomes. Intention-to-treat analysis
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Alfirevic 2007 (Continued)
Selective reporting (reporting bias) Low risk Primary outcome was delivery within 7 days. All other outcomes
reported
Other bias Low risk Baseline characteristics similar
Carlan 1997
Methods RCT
Participants Singleton pregnancies; PPROM; 24 to 34 weeks. N = 92
Interventions TVU CL or not (the control group did not receive TVU CL)
Time TVU CL results available: not specified
Protocol for TVU knowledge group: no
Outcomes Primary: maternal infection
Notes Intention-to-treat; only singletons; PPROM; no protocol (really a safety study for TVU
CL in women with PPROM)
Short TVU CL (< 25 mm): 14/45 (31%) in knowledge group; not done in other group
Funding: not reported
Dates of trial: from May 1993 to June 1996
Setting: Arnold Palmer Hospital for Children and Women, Floride, United States
Conflicts of interest: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomly-generated assignment”
Allocation concealment (selection bias) Low risk “Randomly-generated” assignments in sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study group had weekly US while controls had none
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1% explained
Selective reporting (reporting bias) Low risk Primary outcome was chorioamnionitis. All other outcomes re-
ported
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Carlan 1997 (Continued)
Other bias Unclear risk No baseline characteristics table
Gordon 2016
Methods RCT
Participants Twin pregnancies; asymptomatic and with PTL symptoms; 15 to 34 weeks. N = 125
Interventions TVU CL screening at 15 to 28 weeks, and if PTL symptoms develop or not (the control
group did not receive TVU CL)
Time TVU CL results available: not specified
Protocol for TVU knowledge group: yes
Outcomes Primary: length of gestation
Notes Only abstract published; unclear if intention-to-treat; only twins; protocol for manage-
ment of TVU CL group
Short TVU CL not available
Funding: not reported
Dates of trial: not reported
Setting: not reported, assumed United States
Conflicts of interest: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Different protocols for study and control groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Primary outcome objective - length of gestation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No incomplete outcomes mentioned
Selective reporting (reporting bias) Unclear risk Primary outcome was gestational age at delivery
Other bias Unclear risk Abstract only, so data reported are limited
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Mishra 2018
Methods RCT
Participants Asymptomatic singleton pregnancies at 16 to 24 6/7 weeks. N = 296
Interventions TVU CL performed or not (the control group did not receive TVU CL) at the time of
the routine anatomy screening
Protocol for TVU group: yes
Outcomes Primary: PTB < 37 weeks
Notes Funding: not reported
Dates of trial: July 2014 to December 2015
Setting: Department of Obstetrics & Gynaecology, Postgraduate Institute of Medical
Education and Research, Chandigarh, North India
Conflicts of interest: the authors reported no conflicts of interest
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and physicians knew which group was randomised to
’TVU CL performed’ or ’not performed’
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Lost to follow-up removed from the analysis
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Low risk Baseline characteristics similar
Ness 2007
Methods RCT
Participants Singleton (and 3 twin) pregnancies; uterine contractions or symptoms suggestive of PTL
at 24 to 33 6/7 weeks. N = 100
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Ness 2007 (Continued)
Interventions TVU CL knowledge or not (the control group did receive TVU CL, but results were
blinded to managing physicians)
Time TVU CL results available: not specified
Protocol for TVU knowledge group: yes
Outcomes Primary: time from initial evaluation to discharge
Notes Intention to treat; 97% singletons; protocol for management of TVU CL group, which
included management based on FFN for women with CL 20 to 29 mm
Short TVUCL (< 20mm): 11/51 (22%) in knowledge group; 7/49 (15%) in the control
group
Funding: not reported
Dates of trial: between November 2004 and April 2006
Setting: Thomas Jefferson University Hospital, Philadelphia
Conflicts of interest: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
Allocation concealment (selection bias) Low risk Numbered, sealed, opaque envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and physicians knew which group was randomised to
’knowledge’ or ’no knowledge’
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analyses
Selective reporting (reporting bias) Low risk Primary outcome time from evaluation to discharge. All other
outcomes reported
Other bias Low risk Baseline characteristics similar
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Palacio 2018
Methods RCT
Participants Singleton pregnancies; PTL at 24 to 35 6/7 weeks. N = 149
Interventions TVU CL knowledge or not (the control group did receive TVU CL, but results were
blinded to managing physicians)
Time TVU CL results available: not specified
Protocol for TVU knowledge group: yes
Outcomes Primary: hospital length of stay
Notes 7 women lost to follow-up; only singletons; protocol for management of TVUCL group
Short TVU CL (< 25 mm): 22/75 (29%) in knowledge group; 20/74 (27%) in the
control group
Funding: not reported
Dates of trial: from January 2002 to April 2005
Setting: Hospital Clinic of Barcelona, Spain
Conflicts of interest: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
Allocation concealment (selection bias) Low risk Telephone-operated platform
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and physicians knew which group was randomised to
’knowledge’ or ’no knowledge’
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk 5% of data removed from final analysis
Selective reporting (reporting bias) Unclear risk Length of hospital stay primary outcome
Other bias Low risk Baseline characteristics similar
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Vafaei 2017
Methods RCT
Participants Singleton pregnancies; PTL before 34 weeks. N = 120
Interventions TVU CL performed or not
Protocol for TVU group: yes
Outcomes Primary: Delivery within 7 days
Notes No outcome of interest
Funding: Supported by Vice-Chancellor of Research, Shiraz University of Medical Sci-
ences, Shiraz, Iran
Dates of trial: not reported
Setting: Hafez Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Conflicts of interest: authors declare no conflict of interest
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and physicians knew which group was randomised to
’TVU CL performed’ or ’not performed’
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk None lost to follow-up
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Low risk Baseline characteristics similar
CL: cervical length
FFN: fetal fibronectin
PPROM: preterm premature rupture of membranes
PTL: preterm labour
RCT: randomised controlled trial
TVU: transvaginal ultrasound
US: ultrasound
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Beigi 2005 Compared history - indicated to ultrasound-indicated cerclage
Burwick 2011 Used Cervilenz, which is a plastic instrument to measure the vaginal part of the cervix. This is outside the scope
of our review, which focuses on CL measured exclusively by TVU
Gauthier 2014 Compared TVU CL screening to transperineal ultrasound CL screening, with no control group with ’no knowl-
edge’ of CL
Hosseini 2012 Unclear if randomised to knowledge versus no knowledge of CL. No outcome of interest was reported in cases
versus controls. Only published as an abstract, with no other information available
Kassanos 2001 Compared history-indicated to ultrasound-indicated cerclage.
Lorenz 1990 Control group was not ’no ultrasound’ or ’no knowledge’, but was manual digital cervical exam. Interestingly,
the study group utilized transabdominal ultrasound
Matijevic 2006 The TVU CL information was blinded and not used for management
Owen 1999 TVU information was not used for clinical care and no data on outcomes were provided
Romero 2014 No data on any outcomes of interest for this Cochrane Review were available, even upon direct request, as this
was a trial assessing only visit length and patient attitudes
Schnettler 2013 Compared TVU CL immediately after urination to TVU CL at least 15 minutes after urination, with no control
group with ’no knowledge’ of CL
Simcox 2009 Compared history - indicated to ultrasound-indicated cerclage
Van Dijken 1991 Control group was not ’no ultrasound’ or ’no knowledge’, but was manual digital cervical exam. Interestingly,
the study group utilized transabdominal, not TVU
CL: cervical length
TVU: transvaginal ultrasound
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Characteristics of ongoing studies [ordered by study ID]
NCT01431885
Trial name or title Two methods of diagnosing preterm labor
Methods Parallel open label randomised controlled trial
Participants Symptomatic complaints suggestive of preterm labour, greater than 6 contractions per hour
Interventions Symptomatic preterm labor patients will be randomised to diagnosis of preterm labor by serial digital exami-
nation versus an algorithm incorporating transvaginal ultrasound measurement of cervical length and vaginal
fetal fibronectin
Outcomes Preterm birth < 37 weeks
Starting date August 2011
Contact information Conrad R Chao, University of California, San Francisco. e-mail: cchao@fresno.ucsf.edu
Notes Estimated primary completion date: August 2015
Estimated study completion date: August 2015
NCT02923973
Trial name or title Transvaginal ultrasound cervical length screening in singleton pregnancy with prior spontaneous preterm
birth
Methods Parallel open label randomised trial
Participants Women 18 to 50 years of age, with prior spontaneous preterm delivery 16 0/7 to 36 6/7 weeks and singleton
pregnancies
Interventions Transvaginal ultrasound cervical length screening versus no screening
Outcomes Primary:
Preterm birth (less than 37 weeks)
Secondary:
Gestational age at delivery
Preterm birth (less than 24, 28, 32, 30, and 34 weeks’ gestation)
Birthweight
Low birth weight (< 2500g)
Neonatal death
Composite of adverse perinatal outcomes (necrotizing enterocolitis, intraventricular haemorrhage (grade 3 or
higher), respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy, blood-culture proven sepsis
and neonatal death)
Admission to neonatal intensive care unit
Starting date June 1, 2018
30Cervical assessment by ultrasound for preventing preterm delivery (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
NCT02923973 (Continued)
Contact information Gabriele Saccone, Federico II University, Naples, Italy, e-mail: gabriele.saccone.1990@gmail.com
Notes Estimated primary completion date: December 1, 2020
Estimated study completion date: March 1, 2021
NCT02928302
Trial name or title Transvaginal ultrasound cervical length screening in singleton pregnancy without prior spontaneous preterm
birth
Methods Non-blinded randomised screening trial
Participants Asymptomatic singleton pregnancies without prior spontaneous preterm birth
Interventions Transvaginal ultrasound cervical length screening versus no screening
Outcomes Primary:
Preterm birth (less than 37 weeks)
Secondary:
Preterm birth (less than 24, 28, 32, 30, and 34 weeks’ gestation)
Admission to neonatal intensive care unit
Neonatal death
Birthweight
Composite of adverse perinatal outcomes (necrotizing enterocolitis, intraventricular haemorrhage (grade 3 or
higher), respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy, blood-culture proven sepsis
and neonatal death)
Perinatal death
Starting date July 15, 2018
Contact information Gabriele Saccone, Federico II University, Naples, Italy, e-mail: gabriele.saccone.1990@gmail.com
Notes Estimated primary completion date: September 2019
Estimated study completion date: January 2020
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D A T A A N D A N A L Y S E S
Comparison 1. Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL)
- asymptomatic women with twins
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Preterm birth < 36 weeks 1 125 Risk Ratio (M-H, Fixed, 95% CI) 1.27 [0.85, 1.90]
2 Preterm birth < 34 weeks 1 125 Risk Ratio (M-H, Fixed, 95% CI) 0.62 [0.30, 1.25]
3 Preterm birth < 32 weeks 1 125 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.17, 1.83]
4 Preterm birth < 30 weeks 1 125 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.02, 1.64]
5 Gestational age at delivery 1 125 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.74, 1.14]
6 Maternal hospitalisation for PTL 1 125 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.75, 2.23]
7 Tocolysis 1 125 Risk Ratio (M-H, Fixed, 95% CI) 1.34 [0.74, 2.42]
8 Steroids for fetal lung maturity 1 125 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.49, 1.26]
9 Cervical cerclage 1 125 Risk Ratio (M-H, Fixed, 95% CI) 4.92 [0.24, 100.49]
10 Birthweight (g) 1 250 Mean Difference (IV, Fixed, 95% CI) 142.0 [-9.95, 293.
95]
11 NICU admission 1 250 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.83, 1.55]
Comparison 2. Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL)
- singletons with symptoms of PTL
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Preterm birth < 37 weeks 2 242 Risk Ratio (M-H, Random, 95% CI) 0.59 [0.26, 1.32]
2 Preterm birth < 34 weeks 3 256 Risk Ratio (M-H, Fixed, 95% CI) 0.55 [0.25, 1.20]
3 Preterm birth < 28 weeks 2 137 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Gestational age at delivery
(weeks)
3 290 Mean Difference (IV, Fixed, 95% CI) 0.64 [0.03, 1.25]
5 Birthweight < 2500 g 1 70 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.21, 2.44]
6 Perinatal death 2 138 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Maternal hospitalisation 1 93 Risk Ratio (M-H, Fixed, 95% CI) 2.94 [0.85, 10.16]
8 Tocolysis 2 102 Risk Ratio (M-H, Random, 95% CI) 0.85 [0.11, 6.58]
9 Steroids for fetal lung maturity 2 114 Risk Ratio (M-H, Random, 95% CI) 1.72 [0.15, 19.64]
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Comparison 3. Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL)
- singletons with PPROM
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Birthweight (g) 1 92 Mean Difference (IV, Fixed, 95% CI) 31.0 [-162.16, 224.
16]
2 Chorioamnionitis 1 92 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.34, 1.52]
3 Endometritis 1 92 Risk Ratio (M-H, Fixed, 95% CI) 1.39 [0.33, 5.88]
4 Neonatal infection 1 92 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.50, 2.78]
Comparison 4. Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL)
- asymptomatic singletons
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Preterm birth < 37 weeks 1 296 Risk Ratio (M-H, Fixed, 95% CI) 1.27 [0.61, 2.61]
2 Birthweight (g) 1 296 Mean Difference (IV, Fixed, 95% CI) -10.0 [-135.17, 115.
17]
3 Respiratory distress syndrome
(RDS)
1 296 Risk Ratio (M-H, Fixed, 95% CI) 2.03 [0.38, 10.90]
4 NICU admission 1 296 Risk Ratio (M-H, Fixed, 95% CI) 2.03 [0.19, 22.12]
5 Intraventricular haemorrhage
(IVH)
1 296 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.05, 5.53]
6 Neonatal death 1 296 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.01, 4.19]
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Analysis 1.1. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 1 Preterm birth < 36 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 1 Preterm birth < 36 weeks
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2016 31/63 24/62 100.0 % 1.27 [ 0.85, 1.90 ]
Total (95% CI) 63 62 100.0 % 1.27 [ 0.85, 1.90 ]
Total events: 31 (Knowledge of CL), 24 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 1.17 (P = 0.24)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours knowledge of CL Favours no knowledge of CL
Analysis 1.2. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 2 Preterm birth < 34 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 2 Preterm birth < 34 weeks
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2016 10/63 16/62 100.0 % 0.62 [ 0.30, 1.25 ]
Total (95% CI) 63 62 100.0 % 0.62 [ 0.30, 1.25 ]
Total events: 10 (Knowledge of CL), 16 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 1.35 (P = 0.18)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours knowledge of CL Favours no knowledge of CL
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Analysis 1.3. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 3 Preterm birth < 32 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 3 Preterm birth < 32 weeks
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2016 4/63 7/62 100.0 % 0.56 [ 0.17, 1.83 ]
Total (95% CI) 63 62 100.0 % 0.56 [ 0.17, 1.83 ]
Total events: 4 (Knowledge of CL), 7 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.96 (P = 0.34)
Test for subgroup differences: Not applicable
0.02 0.1 1 10 50
Favours knowledge of CL Favours no knowledge of CL
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Analysis 1.4. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 4 Preterm birth < 30 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 4 Preterm birth < 30 weeks
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2016 1/63 5/62 100.0 % 0.20 [ 0.02, 1.64 ]
Total (95% CI) 63 62 100.0 % 0.20 [ 0.02, 1.64 ]
Total events: 1 (Knowledge of CL), 5 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours knowledge of CL Favours no knowledge of CL
Analysis 1.5. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 5 Gestational age at delivery.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 5 Gestational age at delivery
Study or subgroup Knowledge of CL
No
knowledge
of CL
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Gordon 2016 63 35.7 (2.2) 62 35.5 (3.1) 100.0 % 0.20 [ -0.74, 1.14 ]
Total (95% CI) 63 62 100.0 % 0.20 [ -0.74, 1.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.68)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
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Analysis 1.6. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 6 Maternal hospitalisation for PTL.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 6 Maternal hospitalisation for PTL
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2016 21/63 16/62 100.0 % 1.29 [ 0.75, 2.23 ]
Total (95% CI) 63 62 100.0 % 1.29 [ 0.75, 2.23 ]
Total events: 21 (Knowledge of CL), 16 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours knowledge of CL Favours no knowledge of CL
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Analysis 1.7. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 7 Tocolysis.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 7 Tocolysis
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2016 19/63 14/62 100.0 % 1.34 [ 0.74, 2.42 ]
Total (95% CI) 63 62 100.0 % 1.34 [ 0.74, 2.42 ]
Total events: 19 (Knowledge of CL), 14 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours knowledge of CL Favours no knowledge of CL
Analysis 1.8. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 8 Steroids for fetal lung maturity.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 8 Steroids for fetal lung maturity
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2016 20/63 25/62 100.0 % 0.79 [ 0.49, 1.26 ]
Total (95% CI) 63 62 100.0 % 0.79 [ 0.49, 1.26 ]
Total events: 20 (Knowledge of CL), 25 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours knowledge of CL Favours no knowledge of CL
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Analysis 1.9. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 9 Cervical cerclage.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 9 Cervical cerclage
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2016 2/63 0/62 100.0 % 4.92 [ 0.24, 100.49 ]
Total (95% CI) 63 62 100.0 % 4.92 [ 0.24, 100.49 ]
Total events: 2 (Knowledge of CL), 0 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 1.04 (P = 0.30)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours knowledge of CL Favours no knowledge of CL
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Analysis 1.10. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 10 Birthweight (g).
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 10 Birthweight (g)
Study or subgroup Knowledge of CL
No
knowledge
of CL
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Gordon 2016 126 2457 (540) 124 2315 (677) 100.0 % 142.00 [ -9.95, 293.95 ]
Total (95% CI) 126 124 100.0 % 142.00 [ -9.95, 293.95 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.067)
Test for subgroup differences: Not applicable
-200 -100 0 100 200
Favours knowledge of CL Favours no knowledge of CL
Analysis 1.11. Comparison 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic women with twins, Outcome 11 NICU admission.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 1 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic women with twins
Outcome: 11 NICU admission
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gordon 2016 52/126 45/124 100.0 % 1.14 [ 0.83, 1.55 ]
Total (95% CI) 126 124 100.0 % 1.14 [ 0.83, 1.55 ]
Total events: 52 (Knowledge of CL), 45 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours knowledge of CL Favours no knowledge of CL
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Analysis 2.1. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 1 Preterm birth < 37 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with symptoms of PTL
Outcome: 1 Preterm birth < 37 weeks
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Palacio 2018 21/75 25/74 58.6 % 0.83 [ 0.51, 1.34 ]
Ness 2007 6/46 17/47 41.4 % 0.36 [ 0.16, 0.83 ]
Total (95% CI) 121 121 100.0 % 0.59 [ 0.26, 1.32 ]
Total events: 27 (Knowledge of CL), 42 (No knowledge of CL)
Heterogeneity: Tau2 = 0.23; Chi2 = 2.90, df = 1 (P = 0.09); I2 =66%
Test for overall effect: Z = 1.29 (P = 0.20)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours knowledge of CL Favours no knowledge of CL
41Cervical assessment by ultrasound for preventing preterm delivery (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.2. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 2 Preterm birth < 34 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with symptoms of PTL
Outcome: 2 Preterm birth < 34 weeks
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Palacio 2018 4/59 7/59 43.4 % 0.57 [ 0.18, 1.85 ]
Ness 2007 3/49 6/48 37.6 % 0.49 [ 0.13, 1.85 ]
Alfirevic 2007 2/21 3/20 19.0 % 0.63 [ 0.12, 3.41 ]
Total (95% CI) 129 127 100.0 % 0.55 [ 0.25, 1.20 ]
Total events: 9 (Knowledge of CL), 16 (No knowledge of CL)
Heterogeneity: Chi2 = 0.06, df = 2 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours knowledge of CL Favours no knowledge of CL
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Analysis 2.3. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 3 Preterm birth < 28 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with symptoms of PTL
Outcome: 3 Preterm birth < 28 weeks
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Alfirevic 2007 0/21 0/20 Not estimable
Ness 2007 0/48 0/48 Not estimable
Total (95% CI) 69 68 Not estimable
Total events: 0 (Knowledge of CL), 0 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours knowledge of CL Favours no knowledge of CL
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Analysis 2.4. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 4 Gestational age at delivery (weeks).
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with symptoms of PTL
Outcome: 4 Gestational age at delivery (weeks)
Study or subgroup Knowledge of CL
No
knowledge
of CL
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Palacio 2018 75 37.6 (2.6) 74 37.3 (2.7) 51.2 % 0.30 [ -0.55, 1.15 ]
Alfirevic 2007 21 37.9 (3) 20 37.6 (2.9) 11.4 % 0.30 [ -1.51, 2.11 ]
Ness 2007 51 38.3 (2.1) 49 37.1 (2.9) 37.4 % 1.20 [ 0.20, 2.20 ]
Total (95% CI) 147 143 100.0 % 0.64 [ 0.03, 1.25 ]
Heterogeneity: Chi2 = 1.96, df = 2 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 2.05 (P = 0.040)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 5 Birthweight < 2500 g.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with symptoms of PTL
Outcome: 5 Birthweight < 2500 g
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ness 2007 4/37 5/33 100.0 % 0.71 [ 0.21, 2.44 ]
Total (95% CI) 37 33 100.0 % 0.71 [ 0.21, 2.44 ]
Total events: 4 (Knowledge of CL), 5 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 6 Perinatal death.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with symptoms of PTL
Outcome: 6 Perinatal death
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ness 2007 0/49 0/48 Not estimable
Alfirevic 2007 0/21 0/20 Not estimable
Total (95% CI) 70 68 Not estimable
Total events: 0 (Knowledge of CL), 0 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 7 Maternal hospitalisation.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with symptoms of PTL
Outcome: 7 Maternal hospitalisation
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ness 2007 9/47 3/46 100.0 % 2.94 [ 0.85, 10.16 ]
Total (95% CI) 47 46 100.0 % 2.94 [ 0.85, 10.16 ]
Total events: 9 (Knowledge of CL), 3 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 1.70 (P = 0.089)
Test for subgroup differences: Not applicable
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Analysis 2.8. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 8 Tocolysis.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with symptoms of PTL
Outcome: 8 Tocolysis
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Ness 2007 9/39 2/22 44.9 % 2.54 [ 0.60, 10.72 ]
Alfirevic 2007 7/21 20/20 55.1 % 0.35 [ 0.19, 0.63 ]
Total (95% CI) 60 42 100.0 % 0.85 [ 0.11, 6.58 ]
Total events: 16 (Knowledge of CL), 22 (No knowledge of CL)
Heterogeneity: Tau2 = 1.89; Chi2 = 7.00, df = 1 (P = 0.01); I2 =86%
Test for overall effect: Z = 0.16 (P = 0.88)
Test for subgroup differences: Not applicable
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Analysis 2.9. Comparison 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with symptoms of PTL, Outcome 9 Steroids for fetal lung maturity.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 2 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with symptoms of PTL
Outcome: 9 Steroids for fetal lung maturity
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Alfirevic 2007 18/21 20/20 54.4 % 0.86 [ 0.71, 1.05 ]
Ness 2007 9/39 2/34 45.6 % 3.92 [ 0.91, 16.92 ]
Total (95% CI) 60 54 100.0 % 1.72 [ 0.15, 19.64 ]
Total events: 27 (Knowledge of CL), 22 (No knowledge of CL)
Heterogeneity: Tau2 = 2.83; Chi2 = 11.00, df = 1 (P = 0.00091); I2 =91%
Test for overall effect: Z = 0.44 (P = 0.66)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with PPROM, Outcome 1 Birthweight (g).
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 3 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with PPROM
Outcome: 1 Birthweight (g)
Study or subgroup Knowledge of CL
No
knowledge
of CL
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Carlan 1997 45 1617 (500) 47 1586 (442) 100.0 % 31.00 [ -162.16, 224.16 ]
Total (95% CI) 45 47 100.0 % 31.00 [ -162.16, 224.16 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.75)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with PPROM, Outcome 2 Chorioamnionitis.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 3 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with PPROM
Outcome: 2 Chorioamnionitis
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carlan 1997 9/45 13/47 100.0 % 0.72 [ 0.34, 1.52 ]
Total (95% CI) 45 47 100.0 % 0.72 [ 0.34, 1.52 ]
Total events: 9 (Knowledge of CL), 13 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with PPROM, Outcome 3 Endometritis.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 3 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with PPROM
Outcome: 3 Endometritis
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carlan 1997 4/45 3/47 100.0 % 1.39 [ 0.33, 5.88 ]
Total (95% CI) 45 47 100.0 % 1.39 [ 0.33, 5.88 ]
Total events: 4 (Knowledge of CL), 3 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.45 (P = 0.65)
Test for subgroup differences: Not applicable
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Analysis 3.4. Comparison 3 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - singletons with PPROM, Outcome 4 Neonatal infection.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 3 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - singletons with PPROM
Outcome: 4 Neonatal infection
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carlan 1997 9/45 8/47 100.0 % 1.18 [ 0.50, 2.78 ]
Total (95% CI) 45 47 100.0 % 1.18 [ 0.50, 2.78 ]
Total events: 9 (Knowledge of CL), 8 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.37 (P = 0.71)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic singletons, Outcome 1 Preterm birth < 37 weeks.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic singletons
Outcome: 1 Preterm birth < 37 weeks
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mishra 2018 15/147 12/149 100.0 % 1.27 [ 0.61, 2.61 ]
Total (95% CI) 147 149 100.0 % 1.27 [ 0.61, 2.61 ]
Total events: 15 (Knowledge of CL), 12 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Not applicable
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Analysis 4.2. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic singletons, Outcome 2 Birthweight (g).
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic singletons
Outcome: 2 Birthweight (g)
Study or subgroup Knowledge of CL
No
knowledge
of CL
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Mishra 2018 147 2900 (603) 149 2910 (489) 100.0 % -10.00 [ -135.17, 115.17 ]
Total (95% CI) 147 149 100.0 % -10.00 [ -135.17, 115.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.16 (P = 0.88)
Test for subgroup differences: Not applicable
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Analysis 4.3. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic singletons, Outcome 3 Respiratory distress syndrome (RDS).
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic singletons
Outcome: 3 Respiratory distress syndrome (RDS)
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mishra 2018 4/147 2/149 100.0 % 2.03 [ 0.38, 10.90 ]
Total (95% CI) 147 149 100.0 % 2.03 [ 0.38, 10.90 ]
Total events: 4 (Knowledge of CL), 2 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours knowledge of CL Favours no knowledge of CL
52Cervical assessment by ultrasound for preventing preterm delivery (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.4. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic singletons, Outcome 4 NICU admission.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic singletons
Outcome: 4 NICU admission
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mishra 2018 2/147 1/149 100.0 % 2.03 [ 0.19, 22.12 ]
Total (95% CI) 147 149 100.0 % 2.03 [ 0.19, 22.12 ]
Total events: 2 (Knowledge of CL), 1 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Not applicable
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Analysis 4.5. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic singletons, Outcome 5 Intraventricular haemorrhage (IVH).
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic singletons
Outcome: 5 Intraventricular haemorrhage (IVH)
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mishra 2018 1/147 2/149 100.0 % 0.51 [ 0.05, 5.53 ]
Total (95% CI) 147 149 100.0 % 0.51 [ 0.05, 5.53 ]
Total events: 1 (Knowledge of CL), 2 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 0.56 (P = 0.58)
Test for subgroup differences: Not applicable
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Analysis 4.6. Comparison 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured
cervical length (CL) - asymptomatic singletons, Outcome 6 Neonatal death.
Review: Cervical assessment by ultrasound for preventing preterm delivery
Comparison: 4 Knowledge versus no knowledge of transvaginal ultrasound (TVU)-measured cervical length (CL) - asymptomatic singletons
Outcome: 6 Neonatal death
Study or subgroup Knowledge of CL
No
knowledge
of CL Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mishra 2018 0/147 2/149 100.0 % 0.20 [ 0.01, 4.19 ]
Total (95% CI) 147 149 100.0 % 0.20 [ 0.01, 4.19 ]
Total events: 0 (Knowledge of CL), 2 (No knowledge of CL)
Heterogeneity: not applicable
Test for overall effect: Z = 1.03 (P = 0.30)
Test for subgroup differences: Not applicable
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A P P E N D I C E S
Appendix 1. ICTRP and ClinicalTrials.gov - search methods
ICTRP
Each line was run separately
ultrasound AND preterm
sonography AND preterm
cervical AND length AND pregnancy
cervical AND length AND preterm
ClinicalTrials.gov
Advanced search
Interventional studies | Preterm Labor | ultrasound
Cervical length | Interventional studies | preterm
pregnancy | Interventional studies | cervical length
WH A T ’ S N E W
Date Event Description
30 August 2018 New citation required but conclusions have not changed Conclusions remain unchanged.
30 August 2018 New search has been performed Search updated and two new studies included (Mishra
2018; Vafaei 2017). A ’Summary of findings’ table has
been incorporated.
H I S T O R Y
Protocol first published: Issue 3, 2008
Review first published: Issue 3, 2009
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Date Event Description
28 January 2013 Amended Information added on attrition bias for one study (
Ness 2007).
26 September 2012 New search has been performed Two studies identified from an updated search have
been assessed for eligibility and both have been ex-
cluded. Methods have been updated
26 September 2012 New citation required but conclusions have not
changed
Review updated.
27 January 2012 Amended Search updated. Two trial reports added to Studies
awaiting classification (Burwick 2011; Simcox 2009).
C O N T R I B U T I O N S O F A U T H O R S
Vincenzo Berghella devised the idea, applied for the review, wrote the draft of the review and approved the final edition. Gabriele
Saccone edited and approved the final review, and performed review and analysis of pertinent and included studies. Both review authors
were involved in the update of this review.
Contributions of editorial base
Zarko Alfirevic: Approved the review for publication.
Leanne Jones: Co-ordinated the editorial process. Advised on methodology, interpretation and content. Helped produce the ’Summary
of findings’ tables. Technically edited the review.
Denise Atherton: Updated standard methods, edited and copy edited the review. Co-ordinated peer review process.
Lynn Hampson: Designed and conducted all search strategies. Screened all trial reports, edited the Search methods section, search
results and formatted all references in correct style.
Sarah Perry: Second screened all trial reports.
D E C L A R A T I O N S O F I N T E R E S T
Vincenzo Berghella: is a co-author on one of the included trials (Ness 2007). VB was not involved in the assessment of eligibility or
risk of bias for this trial; it was assessed by Gabriele Saccone.
Gabriele Saccone: is lead author on two ongoing trials (NCT02923973; NCT02928302). GS was not involved in the assessment of
eligibility for these trials; they were assessed by the Cochrane Pregancy and Childbirth Group editorial staff.
56Cervical assessment by ultrasound for preventing preterm delivery (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• National Institute for Health Research, UK.
NIHR Programme of centrally-managed pregnancy and childbirth systematic reviews of priority to the NHS and users of the NHS:
10/4001/02
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
A number of outcomes not prespecified in the original protocol were included in the first review, as listed below. We used the same
outcomes in this revision.
1. Preterm birth (less than 36 weeks)
2. Preterm birth (less than 30 weeks)
3. Birthweight
4. Neonatal infection
5. Chorioamnionitis
6. Endometritis
We added a search of ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform ( ICTRP).
We clarified the inclusion criteria, as follows:
Trials that did not measure the outcome of interest, as well as trials using manual digital cervical exam as control group were excluded.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Cervical Length Measurement [∗methods]; Cervix Uteri [∗diagnostic imaging]; Pregnancy, Multiple; Pregnancy, Twin; Premature Birth
[diagnostic imaging; ∗prevention & control]; Randomized Controlled Trials as Topic
MeSH check words
Female; Humans; Pregnancy
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